Literature DB >> 14506738

High frequency of activated K-ras codon 15 mutant in colorectal carcinomas from Taiwanese patients.

Jaw-Yuan Wang1, Jan-Sing Hsieh, Fang-Ming Chen, Ching-Sheng Yeh, Ketil Alexandersen, Tsung-Jen Huang, David c p Chen, Shiu-Ru Lin.   

Abstract

Colorectal carcinogenesis is regarded as a multistep process resulting from accumulation of genetic alterations, including activation of protooncogenes and inactivation of tumor suppressor genes via signal transduction trigger the stage-wise progression to malignancy. The reported incidence of K-ras mutation detected in general tissue samples ranges from 21-60% in primary colorectal cancers (CRC). To assess the prevalence and spectrum of K-ras mutations in Taiwanese patients with CRC, we analyzed 65 CRC patients by polymerase chain reaction-single strand conformation polymorphism analysis, followed by direct sequencing. K-ras mutations were detected in 43.1% (28 of 65) of the tumors. The mutational hot spots were located at codons 12, 13, 15 and 20, especially with the highest frequency at codon 15. To understand whether the codon 15 mutations in CRC were associated with activation of K-ras oncogene and the alterations of its biocharacteristics, mutant K-ras genes were cloned from tumor tissues and then inserted into expression vector pBKCMV to construct the prokaryotic expression plasmid pK15MCMV. Mutant K-ras genes were expressed at high levels in E. coli and the mutant K-ras proteins were shown to be functional with respect to their well-known specific, high-affinity, GDP/GTP binding. The purified K-ras protein from E. coli was then measured for its intrinsic GTPase activity and the extrinsic GTPase activity in the presence of GTPase-activating protein for ras. We found that the extrinsic GTPase activity of the codon 15 mutant K-ras proteins (p21(K-ras15M)) in the presence of GAP is much lower than that of the wild-type K-ras protein (p21 BN), whereas the intrinsic GTPase activity is nearly the same as that of the wild-type K-ras protein. The results indicated that mutation at the codon 15 of K-ras gene indeed decreased GTPase activity in CRC, however, its association with tumorigenesis of CRC needs be clarified by further studies. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14506738     DOI: 10.1002/ijc.11417

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

1.  Activation of K-RAS by co-mutation of codons 19 and 20 is transforming.

Authors:  Adam Naguib; Catherine H Wilson; David J Adams; Mark J Arends
Journal:  J Mol Signal       Date:  2011-03-03

2.  SMAD4--molecular gladiator of the TGF-beta signaling is trampled upon by mutational insufficiency in colorectal carcinoma of Kashmiri population: an analysis with relation to KRAS proto-oncogene.

Authors:  A Syed Sameer; Nissar A Chowdri; Nidda Syeed; Mujeeb Z Banday; Zaffar A Shah; Mushtaq A Siddiqi
Journal:  BMC Cancer       Date:  2010-06-17       Impact factor: 4.430

3.  The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer.

Authors:  Ching-Wen Huang; Hsiang-Lin Tsai; Yi-Ting Chen; Chun-Ming Huang; Cheng-Jen Ma; Chien-Yu Lu; Chao-Hung Kuo; Deng-Chyang Wu; Chee-Yin Chai; Jaw-Yuan Wang
Journal:  BMC Cancer       Date:  2013-12-13       Impact factor: 4.430

Review 4.  Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies.

Authors:  Qing Ji; Qi Li; Jing Zhou
Journal:  J Exp Clin Cancer Res       Date:  2021-10-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.